The Dopamine Transporter Gene (DAT1) in Obesity and Binge Eating Disorders

2011 ◽  
pp. 2659-2672
Author(s):  
Karen Wight ◽  
Caroline Reid-Westoby ◽  
Caroline Davis
Keyword(s):  
Eating Disorders ◽  
Binge Eating ◽  
Dopamine Transporter ◽  
Transporter Gene ◽  
Dopamine Transporter Gene ◽  
Binge Eating Disorders

scholarly journals Dopamine Transporter Gene (DAT1) Associated with Appetite Suppression to Methylphenidate in a Case–Control Study of Binge Eating Disorder

2007 ◽  
Vol 32 (10) ◽  
pp. 2199-2206 ◽  
Author(s):  
Caroline Davis ◽  
Robert D Levitan ◽  
Allan S Kaplan ◽  
Jacqueline Carter ◽  
Caroline Reid ◽  
...  
Keyword(s):  
Eating Disorder ◽  
Binge Eating ◽  
Dopamine Transporter ◽  
Binge Eating Disorder ◽  
Case Control Study ◽  
Case Control ◽  
Transporter Gene ◽  
Dopamine Transporter Gene ◽  
Appetite Suppression ◽  
Control Study

scholarly journals Cost-of-illness for non-underweight binge-eating disorders

2021 ◽  
Author(s):  
Paul E. Jenkins
Keyword(s):  
Eating Disorders ◽  
Binge Eating ◽  
Economic Impact ◽  
Indirect Costs ◽  
Cost Effective ◽  
Level Of Evidence ◽  
Academic Impairment ◽  
The United Kingdom ◽  
Binge Eating Disorders ◽  
Low Weight

Abstract Purpose This study examined economic costs associated with untreated eating disorders (EDs) characterised by regular binge eating in the absence of low weight. Both direct and indirect costs were assessed, reporting a limited societal perspective of economic impact as some costs were not included. Methods One hundred and twenty six adults seeking treatment for recurrent binge eating were asked to report impairment associated with an ED. Costs were calculated using 2017 prices, including an examination of variables associated with costs. Results Estimated societal costs for the year preceding assessment were £3268.47 (€3758.54) per person. In multivariate analyses, no reliable baseline associates of cost were identified. Conclusion The economic burden of EDs characterised by regular binge eating is significant, and underscores the need for efficacious and cost-effective treatments. Individuals with binge-eating disorders report work impairment and healthcare use that may cost the United Kingdom economy upwards of £3.5 billion (€4bn) per annum. Further studies should consider academic impairment and the economic impact of EDs on families. Level of evidence III: evidence obtained from well-designed cohort or case–control analytic studies.

Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese

2010 ◽  
Vol 116 (1) ◽  
pp. 68-74 ◽  
Author(s):  
San-Yuan Huang ◽  
Hsing-Kang Chen ◽  
Kuo-Hsing Ma ◽  
Mee-Jen Shy ◽  
Jiun-Hsiung Chen ◽  
...  
Keyword(s):  
Dopamine Transporter ◽  
Han Chinese ◽  
Transporter Gene ◽  
Dopamine Transporter Gene

scholarly journals Cocaine and Amphetamine Increase Extracellular Dopamine in the Nucleus Accumbens of Mice Lacking the Dopamine Transporter Gene

2001 ◽  
Vol 21 (9) ◽  
pp. RC141-RC141 ◽  
Author(s):  
Ezio Carboni ◽  
Cécile Spielewoy ◽  
Cinzia Vacca ◽  
Marika Nosten-Bertrand ◽  
Bruno Giros ◽  
...  
Keyword(s):  
Nucleus Accumbens ◽  
Dopamine Transporter ◽  
Transporter Gene ◽  
Dopamine Transporter Gene ◽  
Extracellular Dopamine

Dietary patterns of patients with binge eating disorders with and without night eating

2018 ◽  
Vol 25 (2) ◽  
pp. 321-328
Author(s):  
Yael Latzer ◽  
Adi Elron Yutal ◽  
Miri Givon ◽  
Orna Kabakov ◽  
Sigal Alon ◽  
...  
Keyword(s):  
Eating Disorders ◽  
Binge Eating ◽  
Dietary Patterns ◽  
Night Eating ◽  
Binge Eating Disorders
Sign in / Sign up

Export Citation Format

Share Document